CRH plc (LON:CRH) had its price target reduced by Numis Securities Ltd from GBX 3,170 ($41.69) to GBX 3,000 ($39.46) in a report issued on Wednesday. Numis Securities Ltd currently has an add rating on the stock.
CRH has been the subject of several other research reports. Berenberg Bank dropped their price target on CRH from GBX 3,460 ($45.51) to GBX 3,430 ($45.11) and set a buy rating for the company in a research report on Tuesday, August 29th. Societe Generale reiterated a buy rating and issued a GBX 3,400 ($44.72) price target on shares of CRH in a research report on Monday, October 23rd. UBS AG set a GBX 3,100 ($40.77) price target on CRH and gave the stock a buy rating in a research report on Wednesday, August 30th. Beaufort Securities reiterated a buy rating and issued a GBX 3,200 ($42.09) price target (up previously from GBX 3,100 ($40.77)) on shares of CRH in a research report on Friday, August 25th. Finally, Jefferies Group LLC reiterated a buy rating and issued a GBX 3,190 ($41.96) price target on shares of CRH in a research report on Wednesday. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company has an average rating of Buy and an average price target of GBX 3,196.13 ($42.04).
CRH (CRH) opened at GBX 2,649 ($34.84) on Wednesday. CRH has a 12-month low of GBX 26.98 ($0.35) and a 12-month high of GBX 3,342 ($43.96).
CRH Company Profile
CRH public limited company (CRH plc) is a building materials company. The Company’s segments include Europe Heavyside, Europe Lightside, Europe Distribution, Americas Materials, Americas Products, Americas Distribution and Asia. Europe Heavyside segment is engaged in the manufacturing and supply of aggregates, asphalt, cement, readymixed and precast concrete and landscaping products.
Receive News & Ratings for CRH plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH plc and related companies with MarketBeat.com's FREE daily email newsletter.